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Collagen-Induced Arthritis (CIA) is an experimentally induced and genetically controlled animal 
model of chronic joint inflammation. In rats, there are informative strain differences in susceptibility 
to CIA. DA rats (RTlavl) develop severe CIA after immunization with bovine (BII), chick (CII), or 
homologous rat (RII) type II collagens. In contrast, the MHC-congenic DA.IN(BN) and WF.IN(BN) 
rats (R Tln) are relatively resistant to CIA and develop moderate CIA in response to immunization 
with CII but not BII or RII. We previously found that simultaneous infection with rat cytomegalovirus 
(RCMV) greatly exacerbates the severity of arthritis that develops in BH-immunized DA rats. To 
examine the mechanism of RCMV amplification of CIA, the effect of simultaneous infection with 
RCMV on arthritis and autoimmunity to type II collagen was determined in WF.1N and DA.IN rats 
after immunization with BII, CII and RII. RCMV increased the incidence of CIA and the level of
• autoimmunity to type II collagen (skin-testing and IgG antibody titer) selectively in DA.IN and
WF. IN rats immunized with CII, but not in littermates immunized with BII, although the transient 
reversal of CD4 + /CD8+ mononuclear cell ratios in peripheral blood that is associated with RCMV 
infection occurred equally in both BII- and CII- immunized DA. IN rats. Likewise, RCMV infection 
moderately increased the levels of anti-RH autoimmunity and arthritis in DA rats sub-optimaliy 
immunized with RII but had no consistent effect on either anti-R(I immunity or arthritis in 
RH-immunized DA. IN and WF.ln rats. The data show that RCMV augments arthritis only in rats 
that are gentically susceptible to CIA and that are appropriately immunized with a species of type II 
collagen that is arthritogenic for the MHC-haplotype being tested. Two possible mechanisms are 
suggested by these data: RCMV-associated increases in anti-RII autoimmunity in rats with CIA may 
result from amino acid sequence homologies between RCMV and type II collagen; alternatively, 
virus-induced pro-inflammatory cytokines may activate RH-reactive lymphocytes thereby potentiating 
autoimmunity and arthritis.
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IN T R O D U C T IO N
Immunization of rats with native type II collagen 
derived from sternal or articular cartilage induces an 
autoimmune arthritis, Collagen-Induced Arthritis 
(CIA), that is controlled by genes both linked non­
linked to RT1, the rat M HC1-6. CIA requires the 
development o f complement-fixing, anti-type II colla­
gen antibodies and collagen-reactive C D 4+ T cells7-9. 
The pro-inflammatory cytokines such an IFNy, TNFa,
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and U-l potentiate arthritis in this m odel10-13. Thus, 
clinical expression o f CIA can be modulated by in vivo 
manipulation o f several immune parameters including 
changes in the levels or specificities of certain cyto­
kines, T cell subsets or anti-RII autoantibodies.
The type II collagen molecule is a rod-shaped, heli­
cal, multi-determinant antigen. There are minor dif­
ferences in amino acid sequence among the type II 
collagens of different species. These sequence poly­
morphisms are recognized as foreign with varying 
degrees o f intensity by the immune response systems 
of different, genetically inbred rat strains14-16. In this 
way, they provide an immunogenic stimulus for the 
production o f cross-reactive antibody and the expan­
sion o f autoreactive T cells clones. Amino acid se­
quence homologies exist between type II collagen and 
several proteins encoded in the genomes of the
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Herpesviruses17-19. These common epitopes between 
a virus and type II collagen, provide a potential stim­
ulus to the development o f  collagen autoimmunity and 
arthritis in the infected host due to molecular mim­
icry, a mechanism that can be viewed as analogous to 
immunization with heterologous collagens.
With the long term goal o f elucidating the potential 
roles o f  viruses in human arthritis, we are investigating 
the effect o f  a known, exogenous viral infection, rat 
cytomegalovirus (RCMV), on the rat model o f CIA. 
This system was chosen for several reasons. The host 
defense against viral infection, and particularly CMV 
infections, involves an increased production o f several 
pro-inflammatory cytokines including IFNy, IL-1 and 
TNFa20-24. Murine CMV (MCMV) infections are 
known to elicit NK cells and also both C D 4 + and 
C D 8+ T cells with specificity for virus proteins23-25. 
Also, CMV has sequence homology with class I mole­
cules, thereby potentially modulating antigen- 
presentation to CD8 + T cells by virus infected macro­
phages and B-cells26'27. Thus, CIA is an ideal model 
for evaluating the impact o f acute and chronic viral 
infections on a genetically-controlled, chronic inflam­
matory process that is targeted to a biochemically well 
defined and major component o f joint tissues.
We previously found that RCMV infection signifi­
cantly increases the severity o f CIA induced in DA rats 
by immunization with BII28. RCMV augmentation of 
CIA was associated with elevated numbers o f circulat­
ing B cells, a temporary reversal o f the C D 4+/CD8 + 
T cell ratio in peripheral blood, a transient increase in 
circulating N K  cells and significant increases in anti- 
RII autoimmunity29. However, because o f the hyper­
reactivity o f the DA rat to any of several different 
arthritogenic compounds and because of the proclivity 
o f RCMV to establish latent infections, we could not 
determine conclusively whether RCMV augmentation 
of arthritis was due to the enhancement of anti-RII 
autoimmune reactivity per se  or was due to the local 
production o f cytokines by viral infected joint 
tissues30-33.
RT1 -linked genes exert primary control over the 
level and specificity o f anti-collagen autoimmunity 
that develops in collagen-immunized rats. For exam­
ple, WF (RT1U) and DA (R T lavl) rats are very highly 
susceptible to both BII- and CH-induced CIA while the 
R T ln (MHC-congenic) rat strains, DA. 1N(BN) and 
W F.IN(BN), differentiate between the immunogenic 
and arthritogenic eptiopes expressed on CII versus 
BII14-16. Thus, W F.IN  and D A .IN  develop anti­
collagen antibodies but not arthritis after immuniza­
tion with BII. In contrast, both anti-collagen autoim­
munity and arthritis occur in these two strains after 
immunization with CII. The data presented in this 
report show that RCMV augmentation of arthritis and 
autoimmunity to RII occur in DA. IN  and WF. IN  rats 
only when they are immunized with chick type II
collagen. The data support the hypothesis that RCMV 
enhances CIA by promoting the reactivity o f cells 
involved in the development o f anti-RII autoimmu­
nity and not by antigen non-specific mechanisms such 
as viral infection o f joint tissues.
M E T H O D S
R a ts
DA (R T lavl) inbred rats were from Bantin and 
Kingman (Freemont, CA). W F.IN(M AXX) and 
DA. 1 N(BN) are maintained by sib-sib matings in our 
colony at the University o f Utah and their origins have 
been detailed5. These are inbred, MHC-congenic 
strains that express the R T ln genes o f BN on the 
non-MHC genomes o f WF and DA parental strain rats 
and were developed by classic backcrossing protocols. 
Experimental rats were housed in our animal resource 
facilities at the Veterans Affairs Medical Center in 
pans provided with shavings to prevent trauma to 
arthritic paws.
C ollagens
Chick (CII) and bovine (BII) type II collagens were 
purified from sternal and articular cartilages2. Rat type 
II collagen (RII) was prepared from a rat chondrosar­
coma carried on DA, WF.1N and DA. IN  rats34. After 
removal o f  proteoglycans by extraction into Tris- 
buffered (pH 7.4) 4 M guanidine HCI, type II collagen 
was solubilized by pepsin digestion. Purification steps 
included fractional salt precipitation, dialysis into
0.01 M disodium phosphate and DEAE chromato­
graphy. Purity was assessed by SDS-PAGE. The rat 
chondrosarcoma was a kind gift o f Dr. Michael 
Cremer, Veteran’s Affairs Medical Center, Memphis, 
TN. Protease inhibitors (0.01 M EDTA, 0.001 M Ben- 
zamidine. HCI, 0.01 M N-ethylmaleimide) were in­
cluded in the early stages o f purification and all proce­
dures were performed at 4°C. Collagens are stored 
lyophilized under desiccation at -  20 °C.
R C M V , P ro p a g a tio n  a n d  D etec t ion
Our rat cytomegalovirus was originally obtained from 
Priscott35-37 and has been passaged 8 times through 
specific pathogen free DA rats. Virus is innoculated
1.p. into 4 -6  week old rats and salivary glands are 
harvested and pooled at three weeks. The salivary 
glands are homogenized (10%) in Eagles Minimum  
Essential Medium (MEM) with 10% fetal bovine se­
rum as a stabilizer and stored in 1-2 ml volumes at 
-  70 °C. Concentrations o f RCMV in innoculum pools 
and in salivary gland extracts are quantitated by titra­
tion assays (10-fold dilutions; 1:10 to 1:106) for
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plaque-forming units (PFU) on monolayers o f rat 
embryo fibroblasts grown in 96 well, flat-bottom, 
microti ter plates as previously described28.
C ollagen  I n d u c e d  Arthri t is :  In duc tion  a n d  
A ssessm en t
Our standard protocol for induction o f CIA15 was 
followed. Collagen was dissolved in cold 0.1 N  acetic 
acid at 1 mg per ml and emulsified 1:1 (vol:vol) with 
IFA (Incomplete Freund’s adjuvant; Difco). Rats at 8 
to 12 weeks o f  age are injected intradermally at multi­
ple sites on the back to obtain a final collagen dose o f  
2 mg/kg rat weight (100%). Rats are scored twice 
weekly for arthritis onset and severity. Arthritis is 
evaluated on an expanded scale such that the maxi­
mum possible score per animal is 80 and the maxi­
mum score per paw is 2030. This scoring system in­
cudes an evaluation o f each joint individually, thus 
providing a total score that is effectively weighted for 
articular surface areas. Rats were observed for 60-90  
days after collagen immunization unless otherwise 
stated. Variations on this standard protocol are de­
scribed in the text where appropriate.
R C M V  A u g m e n ta t io n  o f  CIA
Equal numbers of male and female rats were immu­
nized with IFA emulsions o f CII, BII, RII (dose: 0.5,
1.0 or 2.0 mg/kg) or 0.1 N  acetic acid, the collagen 
solvent. Sub-optimum immunization schedules were 
used in some experiments so as to maximize the 
potential degree o f RCMV augmentation o f arthritis. 
The collagen concentrations were adjusted such that 
all rats received the same total amount o f IFA relative 
to their body weight. Collagen emulsions were in­
jected, intradermally on the back; test rats were simul­
taneously administered 5 x  105 to 1 x 106 PFU o f a 
stock RCMV pool or PBS in 0.1 ml volumes by in- 
traperitoneal injections. We have previously shown 
that RCMV alone does not induce arthritis in unim­
munized nor in acetic acid: IFA sham immunized 
emulsion control D A  rats28,29. At the end o f the study, 
the rats were sacrificed and salivary glands were re­
moved, stored at -  80 °C, and subsequently analyzed 
for RCMV by titration assays for viable PFU.
M e a su re m e n t  o f  A n ti-C o l la g en  I m m u n i ty
IgG antibody titers to RII were determined by an 
ELISA assay using 96 well microtiter plates coated 
with native RII, blocked with bovine serum albumin 
and developed with a goat anti-rat IgG (heavy and 
light chain specific) second antibody conjugated with 
horse-radish peroxidase (Cooper Biomedical, Inc.) as
previously detailed3. Sera are tested at 4-fold dilutions 
(initial dilution o f 1:25) and plates are exposed at 4°C  
over night. Positive and negative control sera are run 
on each plate in duplicate. Data are presented as 
antibody units (Ab U/m l) calculated by comparison 
with the linear portion o f a standard curve established 
using a positive control serum pool arbitrarily assigned 
a value o f 100,000 Ab U/m l with RII as the antigen. 
Sera were obtained from all rats at 28 days.
Measurement o f skin-test reactivity to native type II 
collagens has been previously described4. Rats are 
injected intradermally on the shaved abdomen with 
50 ug test collagen in 0.05 ml volumes o f 0 .1 5M NaCl 
in 0.05 M Tris-HCl buffer, pH 7.4 and the diameters 
o f induration and redness are measured at 24, 48, and 
72 hours intervals. Positive skin test responses are 
those with mean diameters o f £: 4 mm at 48 to 72 
hours as calculated from 3 repetitive measurements by 
the same technician. Skin testing was performed at 2 
or 8 weeks. None o f the strains tested, including DA  
males and females, have shown any skin test reactivity 
nor pre-existing IgG antibody to native or denatured 
rat type II collagen under these conditions in naive 
rats.
The ratio o f CD4 + /C D 8 + mononuclear cells in 
peripheral blood was determined by a modification o f 
previously described techniques29 using a Model 2151 
Ortho Cytofluorograph outfitted with an Omnichrome 
argon laser and calculation o f data with a Cicero 
computer by Cytomation. Single color analysis of 
ficol-hypaque purified rat mononuclear cells employed 
the following reagents obtained from Accurate Chem­
ical & Scientific Corp (San Diego, CA): Primary 
(mouse IgG) monoclonal antibodies were: Clone 
W 3/13 HLK to detect T lymphocytes — W 3/13 reacts 
with peripheral T cells, neutrophils (which were re­
moved from the test samples by ficoll-hypaque cen- 
trigugation), brain and plasma cells. It does not react 
with B-cells and was used as a technical control stain 
in the current study. Clone W 3/25 was used to detect 
C D 4+ T cells — W3/25 recognizes the rat CD4 glyco­
protein expressed on the T helper subset o f T cells and 
on peritoneal macrophages which would be absent in 
the test lymphocyte suspension; Clone MRC OX-8 
was used to detect C D 8+ T cells and Natural Killer 
cells (NK cells). The second antibody was a 
fluorescein-conjugated, affinity purified F(ab ')2  frag­
ment o f a donkey anti-mouse IgG (heavy and light 
chain specific) antisera obtained from Jackson 
Immuno-Research Laboratories Inc (West Grove, PA). 
For this analysis, test rats were immunized with BII or 
CII at 1 mg/kg (50% standard dose) and not boosted. 
RCMV or placebo (PBS) was administered by i.p.
F A C S  A n a ly s is  o f  C ircu la t in g  T  C e ll  S u bse ts
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Although DA. IN  rats are resistant to chronic BII- 
induced CIA, DA. IN  males occasionally and sporadi­
cally develop a low incidence o f mild erythema that is 
associated with a slight swelling o f one or two distal 
joints which are tender to touch and manipulation. 
The reaction onsets at 23 to 28 days after immuniza­
tion with BII and is transient, resolving within 72 to 
96 hours. This very weak response occurred in 2/15 
BH-immunized (male) DA. IN rats without RCMV 
infection and in 4/16 Bll-immunized and RCMV in­
fected DA. IN  rats (3 males and 1 female). The severity 
score for this BII induced response was 1.7 ± 4  
(mean ±  S.D.) compared with severity scores ranging 
from 20 to 50 in CH-immunized D A .IN  rats. This 
transient, mild joint inflammation was not observed 
in any o f 23 BH-immunized W F.IN rats in either 
the presence or absence of RCMV. These combined 
results show that RCMV augmentation o f CIA occurs 
only in R T ln rats that are immunized with a species 
source o f type II collagen (chick) that is fully arthrito­
genic for rats with this MHC haplotype.
R C M V  A u g m e n ta t io n  o f  CIA Is N o t  O vertly  
Influenced  by G ender
The data in Table 1 compare CIA in a subpopulation 
of the RCMV-infected and RCMV-non-infected, 
D A .IN  and WF.1N, male and female rats that were 
immunized with CII at 50% and 100% dose ratios and 
presented in Figure 1. RCMV infection primarily af­
fected the incidence o f clinically detectable CIA rather 
than the rate o f onset or the severity o f joint inflam­
mation. Control DA rats simultaneously immunized 
with the same CII emulsions developed CIA in 100% 
incidence by 29 days and with a mean arthritis score of 
63 ± 2 . Sex-associated differences in susceptibility to 
Cll-induced CIA (in the absence o f RCMV) were seen 
in D A .IN  rats but not in W F.IN rats. W F.1N male 
and female rats showed similar responses to CII- 
immunization (37%; 23% respectively) and reached
equivalent incidences o f CIA when infected with 
RCMV (58%; 60%). In contrast, the incidence o f CIA 
in Cll-immunized DA. IN  male rats (6.7%) was much 
lower than that o f CH-immune female D A .IN  rats 
(24%). When infected with RCMV, Cll-immunized  
male and female D A .IN  rats showed the same magni­
tude of increase in the incidence of CIA (2 -3  fold) and 
therefore Cll-immunized and RCMV-infected DA. 1N  
females continued to show a higher incidence o f ar­
thritis (50%) than similarly immunized and RCMV- 
infected D A .IN  males (20%).
Effects R C M V  on A n t i -T y p e  I I  C o llagen  
A u to im m u n i ty  in CII, B II  a n d  R H - I m m u n iz e d  
WF. I N  a n d  DA. I N  R a t s
In association with the higher incidence o f clinical 
arthritis, RCMV increased the incidence o f positive 
skin test responses to CII in DA. IN  rats as measured 8 
weeks after immunization with a single injection o f a 
CII-IFA emulsion at 25% the optimum dose (Table II). 
In prior studies with Bll-immunized DA rats, we 
found the greatest enhancement o f skin-test reactivity 
to RII by RCMV was evidence at 14 days after the 
primary immunization. Thus in a second study, fe­
male D A .IN  rats were immunized with CII at 50% 
dose (1 mg/kg), injected with RCMV (106 PFU) or 
PBS, and skin tested at day 14 with CII and RII. In 
these rats, RCMV infection increased the incidence 
and diameter o f skin test reactivity to 50 ug CII from 
3/6 and 4.3 ± 4 .1  mm (means ±  S.D.) respectively, in 
the absence o f RCMV to 6/6 and 8.5 ± 0 .6  mm in the 
presence of RCMV (p 0.05). Likewise, skin test re­
activity to RII in the day 14 analysis o f CII- 
immunized D A .IN  rats were elevated from 2/6 posi­
tive responses (2 .7±  1.8 mm) in RCMV-negative rats 
to 5/6 positive responses (4.8 ± 1 .7  mm) in the 
RCMV-infected rats.
RCMV infection was also associated with a two to 
three-fold increase in serum IgG anti-RII antibody
Table I Effect of RCMV on Incidence of CIA in Cll-immunized male and female RTl" rats
Rats Arthritis
Strain Sex RCMV Incidence Onset Severity
WF. IN M 0 4/11 31 ± 13 29 ±12
WF. IN M + 7/12 38 + 8 20+1
WF. IN F 0 3/13 32 + 6 21 ±3
WF. IN F + 6/10 42 ±5 18 ±3
DA. IN M 0 1/15 23 ±0 21 ±0
DA. IN M + 3/15 25 ± 3 25 + 15
DA. IN F 0 4/17 23 ±12 31 ±30
DA. IN F + 9/18 25 + 2 30 + 24
Rats were immunized with chick type II collagen as IFA emulsions at I mg/kg or 2 mg/kg and simultaneously injected with 0.1 ml PBS (0) or RCMV (+ ). Data are group 
means + / -  S.D. for arthritis severity (maximum possible score o f 80) and onste of arthritis (days) within a 90 day observation period.
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T A B L E  I I  R C M V  in fe c tio n  in c re a se s  th e  in c id e n c e  o f  a r th r i t i s  
a n d  p o s it iv e  s k in  te s t re s p o n s e s  to  ty p e  II c o lla g en  in  C II-  
im m u n iz e d  D A .I N  ra ts .
S T R A IN R C M V A R T H R IT IS "
( In c id e n c e )
S K IN  T E S T 3 
( in c id e n c e )
D A . I N 0 1/8 0 /8
D A .I N + 5 /8 6 /8
D A 0 4 /5 2 /2
D A + 6 /6 2 /2
a)Rats were immunized with CII as IFA emulsions at 0.5 mg/kg. Skin tests were 
with 50 ug CII in 0.! mi PBS at 8 wks. Positive DTH: £*4 mm diameter at 48-72 
hours. Incidence: No. positive/No. tested.
titer in both male and female D A .IN  and W F.IN rats 
that were immunized with CII at each o f the three 
doses (Figure 2). This increase was statistically signifi­
cant for both the WF. IN (p <  0.05) and the DA. IN  
(p < 0.005) rats. In both strains, the highest levels of 
anti-RII antibody developed in RCMV-infected rats
2 0 ,0 0 0
1 0 ,0 0 0 -1
y — --------------------
0 RCMV
F ig u re  2 R C M V  in fe c tio n  in c re a se s  th e  s e ru m  t i te r s  o f  Ig G  a n t i ­
s y m b o ls )  a n d  fe m a le  (o p e n  s y m b o ls )  W F .I N  a n d  D A .I N  ra ts  
tr ian g le s )  o r  C II  a t 2 m g /k g  (c irc le s ), 1 m g /k g  (sq u a re s ) ,  o r  0 .5  n 
(5  x 10s P F U /m l) .  S e ru m  s a m p le s  w e re  o b ta in e d  a t 2 8  d a y s  a n d  i 
m e a n ± S .D .  re s p o n se s  fo r  g ro u p s  o f  4  to  8 ra ts : S .D . v a lu e s  ra n g e d  
in  th e  p re s e n c e  o f  v iru s . N o te  10 -fo ld  d iffe re n c e  in  a n t ib o d y  i 
re s p o n d e r ) .
that were immunized with CII at 2 mg/kg and not 
boosted. The approximately 10-fold difference in anti- 
RII titers between comparable groups o f WF.1N and 
D A .IN  rats were expected; this large interstrain differ­
ence in serum titers o f anti-RII antibody activity 
is characteristic o f WF versus DA non-MHC 
genomes6,15. In contrast, RCMV did not significantly 
alter the levels o f IgG anti-RII antibody in BII- 
immunized W F.IN rats. A small increase in anti-RII 
antibody was seen in Bll-immunized male DA. IN rats 
which was consistent with the mild transitory joint 
inflammation that occurs, albeit infrequently, in BII- 
immune D A .IN  rats. Statistical analysis confirmed 
that IgG anti-RII antibody levels in Bll-immunized 
rats were not significantly increased by RCMV in 
either WF.1N (t = 1.08) or DA.1N (t = 0.53) rats. Two 
of 3 Bll-immunized, DA, emulsion-control rats devel­
oped arthritis and produced antibody levels of
5,000 ± 1,200 units/ml showing that the BII:IFA emul­
sion used in generating this data was active in produc-
T H S  ETAL.
• 0 RCMV +
[ a n tib o d y  in  C ll- im m u n iz e d  D A .I N  a n d  W F .1 N  ra ts .  M a le  (c lo sed  
:re im m u n iz e d  w ith  IF A  e m u ls io n s  o f  B II a t 2 m g /k g  ( in v e r te d  
eg ( tr ia n g le s )  a n d  w e re  ( + )  o r  w e re  n o t (O ) in fe c te d  w ith  R C M V  
ly zed  fo r  IgG  a n t ib o d y  lev e ls  b y  E L IS A . D a ta  p o in ts  r e p re s e n t  th e  
fro m  10%  to  100%  in  th e  a b se n c e  o f  v iru s  a n d  f ro m  10%  to  50%  
in its  b e tw e e n  W F .I N  (h ig h  r e s p o n d e r )  a n d  D A .I N  (m o d e ra te
V IR A L  A U G M E N T A T IO N  O F  C IA  IN  R A T S  183
ing arthritis and pathogenic anti-RII autoimmunity in 
CIA-susceptible DA rats.
The effect o f RCMV on arthritis and collagen auto­
immunity in D A .IN  and W F.1N rats after immuniza­
tion with autologous RII was also examined 
(Table III). As expected, DA. IN  and W F.1N were low  
responders to RII, showing negative skin test reactivity 
to RII at 56 days and mild to no arthritis. There was 
no consistent effect o f RCMV infection on 28 day 
anti-RII antibody levels nor on 42 or 56 day skin test 
reactivity to RII in RH-immunized DA. IN  rats. As 
previously observed in DA. IN  rats immunized with 
heterologous type II collagens, RH-immunized D A .IN  
rats showed a very low incidence o f a mild and transi­
tory joint inflammation which was not substantially 
increased by RCMV infection. Among Rll-immune 
WF.1N rats, RCMV infection boosted the level o f IgG 
anti-RII antibody by approximately 50% but skin test 
reactivity to RII was negative and none o f the RII- 
immune W F.1N rats developed joint inflammation, 
whether or not they were RCMV-infected.
Among DA rats, which are very susceptible to RII- 
induced CIA, RCMV caused a modest increase in the 
severity o f arthritis (score o f 49 ± 8  vs 64 ± 8 ) and 
tripled the level o f IgG anti-RII antibody. In DA rats 
immunized with this dose o f RII (2 mg/kg), skin test 
reactivity to RII at 56 days was high in the absence o f  
RCMV and was not increased further by RCMV infec­
tion. The effect o f  RCMV on skin test reactivity to RII 
in RH-immunized DA, DA. IN  and WF.1N rats was 
also measured at 14 days. For this analysis, rats were 
immunized at the standard dosage o f RII emulsified 
with IFA but were not boosted at 7 days. Under these 
conditions, RCMV infection increased the rate of on­
set o f arthritis and the level o f skin test reactivity to 
RII at 14 days among RH-immunized DA rats but not 
among DA. IN  nor W F.1N rats (Table III).
Titers o f  IgM anti-RII antibody in 21 day serum 
samples were determined (data not shown) and were 
not consistently altered in RH-immunized DA. IN  or 
WF.1N rats. Neither IgM anti-RII nor IgG anti-RII 
antibodies were detected in 21 day serum from any o f  
6-8  control rats o f all three strains that were infected 
with RCMV but not immunized with collagen.
C D 4  * a n d  C D 8 *  P er iph era l  B lo o d  M on on u clear  
Cells  in R C M V  In fe c te d  R a t s
RCMV infection causes a temporary reversal o f the 
C D 4+ /C D 8 + T cell ratios in naive and BII- 
immunized DA rats29. This response peaks at day 8 
and parallels the induction o f increased NK  cell activ­
ity in peripheral blood. To question the role o f CD8 + 
cytotoxic lymphocytes and/or associated cytokines in 
the RCMV augmentation o f CIA, we determined the 
circulating C D 4+/C D 8 + mononuclear cell ratios in
DA. IN rats at weekly intervals after they were infected 
with RCMV and simultaneously immunized with ei­
ther BII or CII (Table III). Immunization with collagen 
alone did not significantly change the C D 4 +/CD8 + 
mononuclear cell ratios in RCMV non-infected rats 
over time. In contrast, RCMV infected D A .IN  rats 
showed a temporary reversal o f C D4 + /C D 8 + mono­
nuclear cell ratios that was evident at day 7, reached a 
nadir at day 14 and gradually returned to normal by 
day 28. Importantly, this change in the subset compo­
sition o f the circulating mononuclear cell populations 
was seen in both CH-immune and BH-immune DA. IN  
rats although RCMV augments arthritis only in CII- 
immunized DA. IN  rats. Thus, the lack o f augmenta­
tion o f  CIA in the BH-immune R T ln  rats with RCMV 
is not due to an ineffective, aberrant or suboptimal 
mononuclear cell response to RCMV in the BII- 
immunized rats.
In all experiments, salivary glands were obtained from 
experimental and control rats at 60 days, homogenized 
and analyzed for RCMV infectious particles by a 
standard plaque-forming assay as previously 
described28. Equivalent titers o f RCMV plaque form­
ing units (105— 106 PFU/m l o f 10% homogenate) were 
recovered at 56 days from the salivary glands of 
RCMV-infected DA, DA. IN and W F.1N rats regard­
less o f the collagen immunization or the presence or 
absence of arthritis. Thus, comparable levels o f  vire- 
mia likely developed in all three strains although exac­
erbation o f arthritis was strain and collagen specific. 
All control rats (collagen-injected, not RCMV innocu- 
lated) were negative for RCMV in salivary gland ex­
tracts (at 1:100 dilutions) showing that there was no 
horizontal spread o f RCMV during the experimental 
observation times.
There are several mechanisms by which RCMV could 
exacerbate arthritis and autoimmunity in the rat 
model o f CIA: 1) molecular mimicry; 2) induction o f  
pro-inflammatory cytokines; 3) latent infection o f  
joint tissues. All o f these hypothetical mechanisms are 
compatible with our current understanding o f the im- 
munopathology o f CIA. For example, the severity of 
arthritis in the CIA model generally reflects the level o f  
anti-RII autoimmunity. A very sensitive arthritogenic 
response to Rll-immunization is associated with the 
R T lavl haplotype o f DA rats6,31. By introducing viral 
proteins having amino acid sequence homologies with 
type II collagen, RCMV could augment CIA in DA  
rats by providing an antigenic stimulus to type II
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TABLE III RCMV amplifies CIA in RH-immunized DA rats but not in RH-immunized WF.1N nor DA.IN ratsa
Rats












DA. IN 0 3.5+2.4 0/9 1164 + 468 3/10*** 0.8+ 1.7
DA. IN + 3.0±2.8 0/9 1387 + 373 1/8 0.5± 1.1
WF.1N 0 0.0 0/5 1980 ±545 0/12 0.0
WF. IN + 0.0 0/5 3160 ± 1600 0/12 0.0
DA 0 5.5 ±0.5 0/2 2384 ±800 5/5 8.4± 1.0
DA + 9.0± 1.0 3/3 7700 ±3400 5/5 7.3±0.5
3iD A. IN and WF.1N are MHC-congenic strains carrying the R T P  of BN on the non-MHC genomes o f DA and WF. Group I rats were immunized with RII but not boosted. 
Group II rats were immunized with RII, boosted at 7 days but not skin-tested until late in the arthritis.
**Skin testing with 50 RII in PBS; group near diameters ±S.D . in mm.
***Mild transitory arthritis o f  <  5 severity scores com pared to mean score o f 50-60 in RII immune DA rats.
collagen auto-reactive T and B lymphocytes. Alterna­
tively, II-1 and IFNy are transiently elevated during 
acute CMV infections. U-l, IFN-y and TNFa exacer­
bate CIA, presumably by activating synovial cells and 
chondrocytes to release cartilage destroying enzymes. 
Finally, Cytomegaloviruses establish latent infections 
in several cells and tissues important to CIA such as 
macrophages and the bone marrow. CD4 + and CD8 + 
T cells specific for virus proteins are recruited during 
CMV infections23. RCMV infection o f DA joint cells 
and local activation o f anti-viral immune reactivities 
in a tissue that is already compromised by the presence 
of complement-activating, anti-collagen antibodies on 
nearby cartilage surfaces could present clinically as an 
augmented arthritis. In this situation, increased anti- 
RII antibody levels might actually derive from carti­
lage breakdown products and RCMV amplification of 
anti-RII immunity should be most evident late and 
after arthritis onset rather than during the early stages 
of arthritis and acute infection.
One approach to differentiating among these mech­
anisms, is to analyze the antigen-specificity o f  RCMV 
amplification o f CIA. Because DA rats are highly 
susceptible to CIA induction by diverse species of  
heterologous and homologous type II collagen includ­
ing bovine, porcine, human, deer, rat and chick6, it 
was not possible to test for antigen-specificity o f
RCMV augmentation o f CIA using this strain. WF.1N  
and D A .IN  rats were selected for study because they 
develop CIA only after immunization with CII and are 
very resistant to CIA induction by immunization with 
mammalian type II collagens6. Also, past analyses of 
antisera raised in D A .IN  and W F.1N rats, have shown 
that these rats develop significantly different profiles of 
immune reactivity towards a panel o f renatured, 
cyanogen-bromide peptides derived from RII after 
immunization with BII as compared to CII15. Thus, 
there are important differences in epitope recognition 
between R T lavl and R T ln rats in the CIA model. By 
using these two strains under conditions o f sub­
optimum immunization, we were able to demonstrate 
direct correlations between RCMV infection, higher 
incidences o f arthritis, higher, IgG anti-RII serum 
antibody titers, and increased levels o f  skin test re­
sponses to RII and CII in CH-immunized W F.1N and 
D A .IN  rats. Importantly, RCMV infection precipi­
tated arthritis and amplified the immune response to 
RII only in R T ln rats that were immunized with chick 
type II collagen. In contrast, RCMV-infected but BII- 
immunized R T ln rats did not develop arthritis and 
did not show increased levels o f anti-RII autoimmu­
nity at either 14 or 56 days, although these rats expe­
rienced an RCMV viremia similar to that o f their 
Cll-immune siblings. Likewise, RCMV infection en­
TABLE IV The transient effect of RCMV infection on peripheral Mononuclear cell subsets is idential in BII- and CH-immunized 
DA. 1N rats
CD4 + /CD8 + Mononuclear Cell Ratios
Group Day 7 Day 14 Day 21 Day 28
CII + PBS 2.5±0.4 2.5 ±0.4 2.0 ±0.4 2.0±0.4
CII + RCMV 1.1 ±0.1 0.8 ±0.3 1.1 ±0.5 2.4 + 0.7
BII + PBS 2.8±0.5 2.2±0.4 2.4 + 0.5 2.4±0.5
BII + RCMV 1.0 ±0.1 0.6±0.3 0.9±0.3 2.4 ±1.6
DA. IN  rats were immunized with BII or CII at 1 mg/kg and injected i.p. with RCMV (106 PFU) or BPS. CD4 * and CD8* T circulating mononuclear cells were quantitated 
by FACS analysis using specific monoclonal antibodies and FITC-conjugated second antibody. Data are m eans±S.D . o f  3 rats (2 females, I male) at each tim e point. 
CD4*/CD8 * ratios for naive D A .lN x  FACS control rats (n -  6) were 2,2 ±0.2.
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hanced the anti-RII autoimmune reactivity and arthri­
tis in DA rats that were immunized with rat type II 
collagen, but had no significant effect on RII- 
immunized WF. IN and DA. IN  rats, both o f which are 
resistant to RH-induced CIA.
Because o f the hyper-reactivity o f the DA rat to a 
variety o f stimuli, it was o f interest to determine if 
other rat strains were subject to modification o f CIA 
by RCMV infection or if this phenomena was unique 
to DA rats. D A .IN  and WF.1N rats carry the major 
histocompatibility complex (MHC) alleles o f the BN  
rat strain on the non-MHC genomes o f DA and WF 
rats respectively. The finding that RCMV augments 
CIA in both DA. IN and WF.1N rats demonstrates 
that neither R T lavl alleles nor non-MHC genes o f DA  
origin are necessary for viral exacerbation o f arthritis 
and anti-RII immunity. In summary, these data show 
that RCMV augments CIA only in rats that are genet­
ically susceptible to CIA and that are appropriately 
immunized with a species of type II collagen that 
elicits an arthritogenic, autoimmune response to RII 
in that particular strain o f rat. Importantly, this phe­
nomena is not restricted to DA rats.
. RCMV-associated reversals o f CD4 + /C D 8 + mono­
nuclear cell ratios occurred in Bll-immunized D A .IN  
rats without causing an increase in anti-RII immune 
responses and without precipitating clinical arthritis. 
Likewise, we found no evidence for differences in the 
systemic spread of virus particles among BII- and 
CH-immune DA, D A .IN  and W F.IN rats as detected 
by recovery o f inectious (PFU) particles from salivary 
tissue of test rats. The combined data argue against the 
selective RCMV augmentation o f CIA in Cll-immune 
R T 1" rats being due to viral infection o f joint tissues 
because all rats apparently experienced similar acute, 
viremic episodes. These results do not negate the 
possibility that anti-RCMV CD8 + T cells (NK cells or 
CTL’s) plus virus-elicited IL-1 and INFy contribute 
synergistically to the severity o f arthritis in RCMV- 
infected and Cll-immunized R T ln rats. For example, 
administration o f recombinant IL-1 is reported to 
precipitate CIA in mice only if  they are o f  a genetically 
susceptible strain38.
DA female rats develop a more severe arthritis than 
DA males in both the CIA and the adjuvant arthritis 
models. In this study, D A .IN  females suboptimally 
immunized with CII had a higher incidence o f arthritis 
than DA. IN  males. However, RCMV infection aug­
mented CIA in both male and female D A .IN  rats to 
the same extent such that the incidence o f CIA in 
D A .IN  females was more than twice that o f D A .IN  
males regardless o f the presence or absence o f RCMV. 
Likewise, Cll-immunized, WF. IN male and female 
rats (which do not show gender differences in CIA) 
were equally affected by RCMV infection. These data 
argue against RCMV amplification o f CIA being due 
to disruption of the normal levels o f corticosteroids,
sex homones or other sex-linked, pro-inflammatory 
mediators.
Because there is a ten-fold difference in serum anti- 
RII antibody titers between collagen-immunized 
W F.IN  and D A .IN  rats, even though the two strains 
show equivalent clinical CIA phenotypes, the exacer­
bation o f CIA by RCMV cannot be attributed solely to 
an overall increase in total anti-RII autoantibodies. An 
alternative hypothesis, is that RCMV could enhance 
CIA by causing a shift in the epitope specificity o f  
anti-type II collagen reactivity response towards novel 
or more pathogenic determinants on exposed cartilage 
collagen. For example, a major arthritogenic determi­
nant of murine CIA is found on the chick cyanogen- 
bromide peptide CB-113916. a  short amino acid motif 
(F-x-y-Q) was identified in the immunodominant re­
gion o f chick CB-11, in the glycoprotein B o f MCMV, 
and in the mycobacterial heat-shock proteins that is 
associated with the adjuvant arthritis model o f au­
toimmunity in rats17. RTl" strains develop a higher 
antibody response to the CB-11 peptide o f RII when 
immunized with CII as compared to BII that directly 
correlates with the induction o f arthritis in R T ln rats 
by CII but not BII15. Alternatively, rats develop sub- 
stanital immune reactivity to other regions o f RII and 
this is particularly true o f DA rats. There is substantial 
sequence homology between EBV proteins and the 
C-terminal one/fifth o f the helical portion o f human 
type II collagen18,19. This region is a major antigenic 
target in humans with HCMV and EBV infections and 
is analogous to the CB9,7 peptide o f RII, an important 
B cell antigen in the rat model o f CIA15,16. Thus, 
RCMV may increase anti-RII immune reactivity in 
genetically susceptible rats by antigenic mimicry and 
much o f this autoimmunity may be directed towards 
arthritogenic B cell and T cell epitopes o f RII.
In summary, the data in this paper have shown that 
viral infection can magnify the severity o f ongoing CIA 
in association with an increase in autoimmune reactiv­
ity to cartilage constituents but that the phenomenum  
is antigen-specific and occurs only in genetically sus­
ceptible rats. Importantly, neither R T lavl genes nor 
non-RTl genes of the hyper-reactive DA rats are a 
pre-requisite for RCMV-augmentation o f CIA. Also, 
the fact that RCMV infection did not precipitate ar­
thritis in Bll-immunized WF. IN rats, although these 
rats developed substantial anti-RII antibody, argues 
strongly against RCMV-amplification of CIA being due 
to latent joint infections; The two most likely mecha­
nism for amplification o f  CIA are molecular mimicry 
and virus-induced, release o f immunomodulating and 
pro-inflammatory cytokines into joint tissues, draining 
nodes and adjacent bone marrow. These are not mutu­
ally exclusive effects o f RCMV infection and both may 
prove to be important mechanisms o f a virus- 
associated initiation or flaring o f arthritis in humans 
with autoimmune rheumatic disease.
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